13F Portfolios

Spruce Street Capital LP: VAXCYTE INC (PCVX): Quarterly 13F Position History

As of Q1 2026, Spruce Street Capital LP reported 245,709 shares of VAXCYTE INC (PCVX), worth $14.3M and representing 3.4% of its 13F equity book. Quarter-over-quarter share count change: 154,651 (-38.6%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.

Recent initiation: Spruce Street Capital LP first reported PCVX on the Q4 2025 filing — fewer than three quarters of history are available.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 245,709 154,651 -38.6% $14.3M 3.4% $58.1
Q4 2025 400,360 $18.5M 6.1% $46.1

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Spruce Street Capital LP first disclose a PCVX position in 13F-HR filings?

Spruce Street Capital LP first reported VAXCYTE INC (PCVX) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.

What was Spruce Street Capital LP's most recent quarter-over-quarter share-count change in PCVX?

Between Q4 2025 and Q1 2026, Spruce Street Capital LP reduced its PCVX position by 154,651 shares (-38.6%), leaving 245,709 shares at a market value of $14.3M.

Does the implied price-per-share represent Spruce Street Capital LP's cost basis in PCVX?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.